TrialInvestigational new drugs2006

Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx) in combination with topotecan in patients with advanced malignancies.

Hervé Ghesquières et al.PubMed ↗Publisher ↗

No numbers read from the abstract.